Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Finazzi

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Haematologica|January 1, 1997
The Italian Registry of Antiphospholipid AntibodiesG Finazzi
Leukemia|November 5, 2011
How to manage essential thrombocythemiaG Finazzi
Minerva Anestesiologica|April 17, 1999
[Antiphospholipid antibody syndrome]G Finazzi
Haematologica|December 29, 1998
Prophylactic platelet transfusion in acute leukemia: which threshold should be usedG Finazzi
Lupus|May 29, 2012
Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disordersG Finazzi
Current Rheumatology Reports|July 27, 2001
The epidemiology of the antiphospholipid syndrome: who is at risk?G Finazzi
Pathologie-Biologie|April 25, 2001
Efficacy and safety of hydroxyurea in patients with essential thrombocythemiaG Finazzi, T Barbui
Leukemia|July 4, 2008
Evidence and expertise in the management of polycythemia vera and essential thrombocythemiaG Finazzi, T Barbui
Annales De Medecine Interne|September 1, 1996
Feasibility of a randomized clinical trial for the prevention of recurrent thrombosis in the antiphospholipid syndrome: the WAPS project. Provisional Steering Committee of the Warfarin in Antiphospholipid Syndrome (WAPS) StudyG Finazzi, T Barbui
Lupus|August 1, 1994
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?T Barbui, G Finazzi
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Haematologica|January 1, 1997
The Italian Registry of Antiphospholipid AntibodiesG Finazzi
Leukemia|November 5, 2011
How to manage essential thrombocythemiaG Finazzi
Minerva Anestesiologica|April 17, 1999
[Antiphospholipid antibody syndrome]G Finazzi
Haematologica|December 29, 1998
Prophylactic platelet transfusion in acute leukemia: which threshold should be usedG Finazzi
Lupus|May 29, 2012
Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disordersG Finazzi
Current Rheumatology Reports|July 27, 2001
The epidemiology of the antiphospholipid syndrome: who is at risk?G Finazzi
Pathologie-Biologie|April 25, 2001
Efficacy and safety of hydroxyurea in patients with essential thrombocythemiaG Finazzi, T Barbui
Leukemia|July 4, 2008
Evidence and expertise in the management of polycythemia vera and essential thrombocythemiaG Finazzi, T Barbui
Annales De Medecine Interne|September 1, 1996
Feasibility of a randomized clinical trial for the prevention of recurrent thrombosis in the antiphospholipid syndrome: the WAPS project. Provisional Steering Committee of the Warfarin in Antiphospholipid Syndrome (WAPS) StudyG Finazzi, T Barbui
Lupus|August 1, 1994
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?T Barbui, G Finazzi
Pageof 14